GLP-1, or glucagon-like peptide-1 drugs, are a synthetic version of the body’s naturally occurring hormone that reduces appetite and slows down the rate at which food leaves the stomach. Originally developed to treat diabetes, GLP-1s’ popularity has skyrocketed because of their use for weight loss. In 2023, GLP-1s alone accounted for nearly 7% of the Read More
In this article, we will look at ISO 31030 and discuss how companies can use this benchmark to review their own risk management strategies for domestic and international travel. Business travel has changed considerably since the pandemic. Whether it’s heightened awareness about illness or increased threats from civil unrest and natural disasters, companies should reassess Read More
This story demonstrates the success that Berkley Edge can have in helping control high-dollar claims.
This case study shows the benefits of having an independent Stop Loss carrier focused on the right care at the right price.
Read our October 2023 report on the cell and gene therapy market
Read our April 2023 report on the cell and gene therapy market
Berkley Accident and Health is committed to helping our policyholders offer affordable, high-quality health benefits. One of the tangible ways we do that is through our Berkley Edge program. Recently, our Berkley Edge team was conducting a routine review for our policyholder, a well-known west coast symphony orchestra, when they came across the claim for Read More
Recently, our Berkley Edge team helped a Stop Loss policyholder lower the cost of an air ambulance transport for a patient suffering an acute heart attack. During a routine claim review, our Berkley Edge team noticed a client had not received any discounts on an air ambulance charge. Our team identified untapped savings and shared Read More